JP2002029988A - Corium collagen fiber bundle-restructuring agent and composition containing the same - Google Patents
Corium collagen fiber bundle-restructuring agent and composition containing the sameInfo
- Publication number
- JP2002029988A JP2002029988A JP2000218808A JP2000218808A JP2002029988A JP 2002029988 A JP2002029988 A JP 2002029988A JP 2000218808 A JP2000218808 A JP 2000218808A JP 2000218808 A JP2000218808 A JP 2000218808A JP 2002029988 A JP2002029988 A JP 2002029988A
- Authority
- JP
- Japan
- Prior art keywords
- collagen fiber
- fiber bundle
- plant
- essence
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 65
- 108010035532 Collagen Proteins 0.000 title claims abstract description 65
- 229920001436 collagen Polymers 0.000 title claims abstract description 65
- 239000000835 fiber Substances 0.000 title claims abstract description 63
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title description 5
- 241000196324 Embryophyta Species 0.000 claims abstract description 33
- 230000037303 wrinkles Effects 0.000 claims abstract description 24
- 241000219926 Myrtaceae Species 0.000 claims abstract description 18
- 244000223014 Syzygium aromaticum Species 0.000 claims abstract description 7
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 7
- 239000002798 polar solvent Substances 0.000 claims abstract description 7
- 235000020030 perry Nutrition 0.000 claims abstract description 6
- 230000002500 effect on skin Effects 0.000 claims description 32
- 210000003491 skin Anatomy 0.000 claims description 31
- 210000004207 dermis Anatomy 0.000 claims description 28
- 238000002360 preparation method Methods 0.000 claims description 26
- 238000007634 remodeling Methods 0.000 claims description 19
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 1
- 230000006872 improvement Effects 0.000 abstract description 5
- 230000002265 prevention Effects 0.000 abstract description 2
- 206010040954 Skin wrinkling Diseases 0.000 description 20
- 230000000694 effects Effects 0.000 description 18
- 239000000686 essence Substances 0.000 description 14
- -1 ethanol and methanol Chemical class 0.000 description 10
- 239000000047 product Substances 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 208000035475 disorder Diseases 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 102000016942 Elastin Human genes 0.000 description 4
- 108010014258 Elastin Proteins 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 229920002549 elastin Polymers 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 241000266331 Eugenia Species 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 244000045719 Syzygium Species 0.000 description 1
- 235000012096 Syzygium samarangense Nutrition 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 125000005131 dialkylammonium group Chemical group 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、真皮コラーゲン線
維束再構築剤及びそれを含有する、化粧料などの皮膚外
用剤に関する。The present invention relates to an agent for reconstructing dermal collagen fiber bundles and an external preparation for skin such as cosmetics containing the agent.
【0002】[0002]
【従来の技術】人間は年齢とともにその形態が変化し、
老化の兆候を見せる。皮膚に於けるこの様な兆候の一つ
にしわの形成が挙げられ、この様な兆候の形成の抑制が
化粧料の大きなテーマとなっている。この様なしわの形
成について、その発生メカニズムとしては1)エラスチ
ンなどの皮膚弾力線維の断裂、断片化などに伴う弾力損
失や2)真皮コラーゲン線維束構造の崩壊乃至はその構
造の乱れ等があるといわれている。このうち、1)エラ
スチンなどの皮膚弾力線維の断裂、断片化などに伴う弾
力損失については、エラスチンの補給や大豆蛋白などに
よるエラスチンの断絶の抑制等の対応策が挙げられてい
るが、2)真皮コラーゲン線維束構造の崩壊乃至はその
構造の乱れに対しては、僅かにウルソール酸及びその誘
導体に真皮コラーゲン線維束の再構築作用が知られてい
るにすぎず、真皮コラーゲン線維束構造を再構築する、
新たな真皮コラーゲン線維束再構築剤の開発が望まれて
いた。2. Description of the Related Art Human form changes with age.
Show signs of aging. One such sign on the skin is the formation of wrinkles, and suppression of the formation of such sign is a major theme of cosmetics. Regarding the formation of such wrinkles, the mechanism of occurrence includes 1) loss of elasticity due to rupture or fragmentation of skin elastic fibers such as elastin, and 2) collapse of dermis collagen fiber bundle structure or disorder of its structure. It is said that. Among them, 1) countermeasures such as replenishment of elastin and suppression of disconnection of elastin by soybean protein etc. are mentioned for the loss of elasticity due to rupture and fragmentation of skin elastic fibers such as elastin, 2) With respect to the collapse of the dermis collagen fiber bundle structure or the disorder of the structure, only ursolic acid and its derivatives are known to have the effect of reconstructing the dermis collagen fiber bundle, and the dermal collagen fiber bundle structure is restored. To construct,
Development of a new dermis collagen fiber bundle remodeling agent has been desired.
【0003】一方、チョウジノキ(Syzygium aromaticu
m L. MERR. Et PERRY)などのフトモモ科(Myrtaceae)
の植物はその植物体のエッセンスに、しゃっくり、嘔
吐、胃痛、腹痛を軽減し、又子宮収縮作用、血管拡張作
用などの薬理作用を有する物質を含んでいることは既に
知られていることであるが、真皮コラーゲン線維束を再
構築する作用を有する物質を含んでいることは全く知ら
れていなかったし、この様な植物のエッセンスを皮膚外
用剤に含有させて、真皮コラーゲン線維束構造を整え、
しわの改善或いは予防を行うことも全く知られていなか
った。[0003] On the other hand, Syzygium aromaticu
Myrtaceae, such as m L. MERR. Et PERRY
It is already known that the plant's essence contains substances that reduce hiccups, vomiting, stomach pain and abdominal pain, and have pharmacological effects such as uterine contraction and vasodilation. However, it was not known at all that it contained a substance having an action of reconstructing the dermal collagen fiber bundle, and the dermal collagen fiber bundle structure was prepared by incorporating the essence of such a plant into an external preparation for skin. ,
It was not known at all to improve or prevent wrinkles.
【0004】[0004]
【発明が解決しようとする課題】本発明は、この様な状
況下為されたものであり、真皮コラーゲン線維束構造を
再構築する、新たな真皮コラーゲン線維束再構築剤を提
供することを課題とする。SUMMARY OF THE INVENTION The present invention has been made under such circumstances, and it is an object of the present invention to provide a new dermis collagen fiber bundle reconstructing agent for reconstructing a dermal collagen fiber bundle structure. And
【0005】[0005]
【課題の解決手段】この様な状況に鑑みて、本発明者ら
は、真皮コラーゲン線維束構造を再構築する、新たな真
皮コラーゲン線維束再構築剤を求めて鋭意研究努力を重
ねた結果、フトモモ科(Myrtaceae)の植物のエッセン
スにそのような作用を見いだし発明を完成させた。即
ち、本発明は次に示す技術に関するものである。 (1)フトモモ科(Myrtaceae)の植物のエッセンスか
らなる真皮コラーゲン線維束再構築剤。 (2)フトモモ科(Myrtaceae)の植物が、フトモモ科
チョウジノキ(Syzygiumaromaticum L. MERR. Et PERR
Y。)であることを特徴とする、(1)に記載の真皮コ
ラーゲン線維束再構築剤。 (3)植物体のエッセンスが、全草或いは、葉部、茎
部、根部、果実、種子、花蕾から選ばれる1種乃至は2
種以上からなる極性溶媒抽出物乃至はその溶媒除去物で
あることを特徴とする、(1)又は(2)に記載の真皮
コラーゲン線維束再構築剤。 (4)(1)〜(3)何れか一項に記載の真皮コラーゲ
ン線維束再構築剤を含有する、しわの改善或いは予防用
の皮膚外用剤。 (5)しわが真皮コラーゲン線維束の崩壊或いは構造の
乱れに起因するものであることを特徴とする、(4)に
記載の植物体のエッセンス。 (6)フトモモ科(Myrtaceae)の植物のエッセンスを
含有することを特徴とする、真皮コラーゲン線維束の崩
壊或いは構造の乱れに起因するしわの処置用の皮膚外用
剤。 (7)フトモモ科(Myrtaceae)の植物が、フトモモ科
チョウジノキ(Syzygiumaromaticum L. MERR. Et PERR
Y)であることを特徴とする、(6)に記載の皮膚外用
剤。 (8)植物体のエッセンスが、花蕾、葉部、茎部、根
部、全草から選ばれる1種乃至は2種以上からなる極性
溶媒の抽出物乃至はその溶媒除去物であることを特徴と
する、(6)又は(7)に記載の皮膚外用剤。In view of such a situation, the present inventors have made intensive research efforts in search of a new dermis collagen fiber bundle reconstructing agent for reconstructing the dermis collagen fiber bundle structure. The inventors have found such an effect in the essence of plants of the family Myrtaceae and completed the invention. That is, the present invention relates to the following technology. (1) A dermis collagen fiber bundle remodeling agent comprising the essence of a plant of the family Myrtaceae. (2) The plant of the family Myrtaceae is myrtaceae (Syzygiumaromaticum L. MERR. Et PERR)
Y. The dermal collagen fiber bundle remodeling agent according to (1), which is characterized in that: (3) The essence of the plant body is one or two selected from whole plants or leaves, stems, roots, fruits, seeds, and flower buds.
The dermal collagen fiber bundle remodeling agent according to (1) or (2), which is a polar solvent extract or a solvent-removed product comprising at least one species. (4) A skin external preparation for improving or preventing wrinkles, comprising the dermis collagen fiber bundle remodeling agent according to any one of (1) to (3). (5) The essence of the plant according to (4), wherein the wrinkles are caused by collapse of the dermis collagen fiber bundle or disorder of the structure. (6) A skin external preparation for treating wrinkles caused by disruption of dermal collagen fiber bundles or structural disorder, comprising an essence of a plant of the family Myrtaceae. (7) The plant of the family Myrtaceae is Myrtaceae, and the plant of the family Myrtaceae is Syzygiumaromaticum L. MERR. Et PERR.
The external preparation for skin according to (6), which is characterized by Y). (8) The essence of a plant is an extract of a polar solvent consisting of one or two or more kinds selected from flower buds, leaves, stems, roots, and whole plants or a solvent-removed product thereof. The external preparation for skin according to (6) or (7).
【0006】[0006]
【発明の実施の形態】(1) 本発明の真皮コラーゲン
線維束再構築剤 本発明の真皮コラーゲン線維束再構築剤は、フトモモ科
(Myrtaceae)の植物のエッセンスからなる。ここで、
本発明でいうエッセンスとは、植物体それ自身、植物体
を乾燥、細切、粉砕など加工した加工物、植物体乃至は
その加工物に溶媒を加えて抽出した溶媒抽出物、抽出物
から溶媒を除去した抽出物の溶媒除去物、それらをカラ
ムクロマトグラフィーや液液抽出など精製した精製物な
どの総称を意味する。本発明のエッセンスに適用するフ
トモモ科チョウジノキ(Syzygiumaromaticum L. MERR.
Et PERRY.他に学名でEugenia caryophyllata THUNB.や
Eugenia aromaticum BAILL. non BERG.と表現すること
もある)等が好ましく例示できる。本発明のエッセンス
の調製に用いる植物体の部位としては、植物体のいずれ
の部位も使用できるが、特に好ましいものは花蕾を乾燥
したものである。これはこの部位に真皮コラーゲン線維
束を再構築する成分が多く含まれているためである。
又、本発明のエッセンスとしては、極性溶媒抽出物或い
はその溶媒除去物が特に好ましく例示でき、極性溶媒と
しては、エタノールやメタノールなどのアルコール類、
酢酸エチルや蟻酸メチルなどのエステル類、アセトンや
メチルエチルケトン等のケトン類、ジエチルエーテルや
テトラヒドロフランなどのエーテル類、クロロホルムや
塩化メチレン等のハロゲン化炭化水素類、水等から選ば
れる1種乃至は2種以上が好ましく例示できる。これら
の内、特に好ましいものは、水及びアルコールから選ば
れる1種乃至は2種以上である。この様な抽出物乃至は
その溶媒除去物は、植物体乃至はその加工物に1〜10
倍量の溶媒を加え、室温であれば数日間、沸点付近の温
度であれば、数時間浸漬すればよい。溶媒除去は、蒸発
乾固、減圧濃縮、凍結乾燥いずれも可能である。もっと
も好ましいものは減圧濃縮と凍結乾燥である。本発明の
皮膚外用剤に於いては、これら真皮コラーゲン線維束再
構築剤は唯一種を含有させることもできるし、二種以上
を含有させることもでき、好ましい含有量としては、
0.01〜10重量%、更に好ましくは0.1〜5重量
%が例示できる。これは、少なすぎると効果を発揮しな
い場合があり、多すぎても効果が頭打ちになり、処方の
自由度が損なわれる場合があるからである。本発明の真
皮コラーゲン線維束再構築剤は、老化や光などによって
崩れた真皮コラーゲン線維束を再構築し、正常な構造に
戻す作用及び真皮コラーゲン線維束構造が光や老化によ
り崩れるのを防ぐ作用を有し、この様な作用によりしわ
を改善したり、しわが形成するのを抑制したりする作用
を有する。本発明の真皮コラーゲン線維束再構築剤がそ
の作用を発揮するしわは、真皮コラーゲン線維束の崩壊
や構造の乱れに起因するものに適用するのが好ましい。BEST MODE FOR CARRYING OUT THE INVENTION (1) Agent for Reconstructing Dermal Collagen Fiber Bundle of the Present Invention The agent for reconstructing dermal collagen fiber bundle of the present invention comprises the essence of a plant belonging to the family Myrtaceae. here,
The essence referred to in the present invention is a plant itself, a processed product obtained by drying, shredding, pulverizing, etc., a plant, or a solvent extract obtained by adding a solvent to the plant or the processed product, or a solvent extracted from the extract. It is a generic term for the solvent-extracted product of the extract from which is removed, and the purified product obtained by purifying them by column chromatography or liquid-liquid extraction. Myrtaceae (Syzygiumaromaticum L. MERR.) Applied to the essence of the present invention
Et PERRY. Eugenia caryophyllata THUNB.
Eugenia aromaticum BAILL. Non BERG.). Although any part of the plant can be used as the part of the plant used for preparing the essence of the present invention, a particularly preferred one is a dried flower bud. This is because this site contains many components for reconstructing the dermal collagen fiber bundle.
Further, as the essence of the present invention, a polar solvent extract or a solvent-removed product thereof can be particularly preferably exemplified. Examples of the polar solvent include alcohols such as ethanol and methanol,
One or two selected from esters such as ethyl acetate and methyl formate, ketones such as acetone and methyl ethyl ketone, ethers such as diethyl ether and tetrahydrofuran, halogenated hydrocarbons such as chloroform and methylene chloride, and water. The above can be preferably exemplified. Of these, particularly preferred are one or more selected from water and alcohol. Such an extract or its solvent-removed product is added to a plant or its processed product in an amount of 1 to 10%.
A double amount of the solvent may be added and immersed for several days at room temperature or several hours at a temperature near the boiling point. The solvent can be removed by evaporation to dryness, concentration under reduced pressure, or freeze drying. Most preferred are vacuum concentration and lyophilization. In the skin external preparation of the present invention, these dermis collagen fiber bundle remodeling agents may contain only one kind, or may contain two or more kinds.
0.01 to 10% by weight, more preferably 0.1 to 5% by weight can be exemplified. This is because if the amount is too small, the effect may not be exhibited, and if the amount is too large, the effect may reach a plateau and the flexibility of prescription may be impaired. The dermis collagen fiber bundle remodeling agent of the present invention reconstructs the dermis collagen fiber bundle that has collapsed due to aging, light, or the like, and has an effect of returning to a normal structure and an effect of preventing the dermal collagen fiber bundle structure from being collapsed by light or aging. It has the effect of improving wrinkles and suppressing the formation of wrinkles by such an action. The wrinkles exerted by the dermis collagen fiber bundle reconstituting agent of the present invention are preferably applied to those caused by collapse of the dermal collagen fiber bundles or structural disorder.
【0007】(2) 本発明の皮膚外用剤 本発明の皮膚外用剤は、上記真皮コラーゲン線維束再構
築剤を含有することを特徴とする。本発明の皮膚外用剤
としては、化粧料、皮膚外用医薬組成物などが好ましく
例示でき、中でも化粧料に適用するのが特に好ましい。
これは本発明の真皮コラーゲン線維束再構築剤の作用が
緩和であり、加えて、このものの安全性が極めて高いた
め、長期連用に好適であるからである。本発明の皮膚外
用剤は、含有する真皮コラーゲン線維束再構築剤の効果
により、真皮コラーゲン線維束の崩壊又は構造の乱れに
起因するしわの改善と予防に優れた作用を発揮する。
又、しわに至らないまでも、同様のメカニズムによって
生じるキメのあれやはりの低下についても改善或いは予
防する作用を示す。言い換えれば、真皮コラーゲン線維
束構造の崩壊や構造の乱れに起因して起こる様々な生体
に好ましくない事象を予防或いは改善し、美肌を具現化
する作用を示す。この様な用途に用いることが本発明の
皮膚外用剤に於いては好ましい。特筆すべきは、真皮コ
ラーゲン線維束の崩壊や構造の乱れによって生じるシワ
への効果であって、この様な効果を発揮する皮膚外用剤
は極めてまれである。従って、本発明の皮膚外用剤は、
この様なメカニズムで起こるしわ用に適用することが好
ましい。本発明の皮膚外用剤に於いては、前記本発明の
真皮コラーゲン線維束再構築剤以外に、通常皮膚外用剤
で使用される任意成分を含有することができる。かかる
任意成分としては、例えば、スクワラン、ワセリン、マ
イクロクリスタリンワックス等の炭化水素類、ホホバ
油、カルナウバワックス,オレイン酸オクチルドデシル
等のエステル類、オリーブ油、牛脂、椰子油等のトリグ
リセライド類、ジメチコンやフェメチコン、アモジメチ
コン等のシリコーン類、ステアリン酸、オレイン酸、リ
チノレイン酸等の脂肪酸、オレイルアルコール、ステア
リルアルコール、オクチルドデカノール等の高級アルコ
ール、スルホコハク酸エステルやポリオキシエチレンア
ルキル硫酸ナトリウム等のアニオン界面活性剤類、アル
キルベタイン塩等の両性界面活性剤類、ジアルキルアン
モニウム塩等のカチオン界面活性剤類、ソルビタン脂肪
酸エステル、脂肪酸モノグリセライド、これらのポリオ
キシエチレン付加物、ポリオキシエチレンアルキルエー
テル、ポリオキシエチレン脂肪酸エステル等の非イオン
界面活性剤類、ポリエチレングリコール、グリセリン、
1,3−ブタンジオール等の多価アルコール類、キサン
タンガム、グァーガム、カルボキシビニルポリマー、カ
チオン化セルロースエーテル、カチオン化グァーガムな
どの増粘・ゲル化剤、酸化防止剤、紫外線吸収剤、香
料、色材、防腐剤、粉体等が好ましく例示できる。本発
明の皮膚外用剤は、これらの任意成分と必須の成分とを
常法に従って処理することにより、本発明の皮膚外用剤
は製造することができる。又、上記真皮コラーゲン線維
束再構築剤を上記の真皮コラーゲン線維束再構築の目的
で含有させなくとも、これらのエッセンスを含有すれ
ば、前記のしわに対する作用が得られるので、この様な
エッセンスを含有する真皮コラーゲン線維束の崩壊又は
構造の乱れに起因するしわの予防又は改善のための皮膚
外用剤も、本発明の皮膚外用剤の技術的範囲に属する。(2) External preparation for skin of the present invention The external preparation for skin of the present invention is characterized by containing the above-mentioned agent for reconstructing dermal collagen fiber bundles. As the external preparation for skin of the present invention, cosmetics, a pharmaceutical composition for external use on skin and the like can be preferably exemplified, and it is particularly preferable to apply to cosmetics.
This is because the action of the dermis collagen fiber bundle remodeling agent of the present invention is moderated, and in addition, the safety is extremely high, so that it is suitable for long-term continuous use. The external preparation for skin of the present invention exerts an excellent effect on improvement and prevention of wrinkles caused by collapse of the dermal collagen fiber bundle or structural disorder due to the effect of the dermis collagen fiber bundle reconstruction agent contained therein.
In addition, even if wrinkles do not occur, it also has the effect of improving or preventing the reduction of texture caused by the same mechanism. In other words, it has the effect of preventing or improving various unfavorable biological events caused by the collapse of the dermal collagen fiber bundle structure or the disorder of the structure, and embodying beautiful skin. Use in such applications is preferred in the skin external preparation of the present invention. What is noteworthy is the effect on wrinkles caused by the collapse of the dermal collagen fiber bundle and the disorder of the structure, and skin external preparations that exhibit such effects are extremely rare. Therefore, the skin external preparation of the present invention,
It is preferable to apply to wrinkles generated by such a mechanism. The external preparation for skin of the present invention may contain, in addition to the agent for reconstructing dermal collagen fiber bundles of the present invention, optional components usually used in external preparations for skin. Such optional components include, for example, hydrocarbons such as squalane, petrolatum, microcrystalline wax, jojoba oil, carnauba wax, esters such as octyldodecyl oleate, triglycerides such as olive oil, tallow, coconut oil, dimethicone, and the like. Silicones such as femethicone and amodimethicone; fatty acids such as stearic acid, oleic acid and ritinoleic acid; higher alcohols such as oleyl alcohol, stearyl alcohol and octyldodecanol; anionic surface activities such as sulfosuccinates and sodium polyoxyethylene alkyl sulfate. Agents, amphoteric surfactants such as alkyl betaine salts, cationic surfactants such as dialkylammonium salts, sorbitan fatty acid esters, fatty acid monoglycerides, polyoxyethylenes thereof Addendum, polyoxyethylene alkyl ethers, nonionic surfactants such as polyoxyethylene fatty acid esters, polyethylene glycol, glycerine,
Polyhydric alcohols such as 1,3-butanediol, xanthan gum, guar gum, carboxyvinyl polymer, cationized cellulose ether, cationized guar gum, and other thickening / gelling agents, antioxidants, ultraviolet absorbers, fragrances, coloring materials , Preservatives, powders and the like can be preferably exemplified. The external preparation for skin of the present invention can be produced by treating these optional and essential components according to a conventional method. Further, even if the dermis collagen fiber bundle remodeling agent is not contained for the purpose of reconstructing the dermis collagen fiber bundle, if these essences are contained, the action on the wrinkles can be obtained. A topical skin preparation for preventing or improving wrinkles caused by disruption of the dermal collagen fiber bundles or structural disorder contained therein also belongs to the technical scope of the topical skin preparation of the present invention.
【0008】[0008]
【実施例】以下に、実施例を挙げて本発明について更に
詳細に説明を加えるが、本発明がこれら実施例にのみ限
定されないことはいうまでもない。EXAMPLES Hereinafter, the present invention will be described in more detail with reference to Examples, but it goes without saying that the present invention is not limited to only these Examples.
【0009】<実施例1>フトモモ科チョウジノキ(Sy
zygium aromaticum L. MERR. Et PERRY.)の花蕾を乾燥
させたもの500gに5lのメタノールを加え、室温で
1週間浸漬し、濾過して、減圧濃縮し、本発明の真皮コ
ラーゲン線維束再構築剤1を35g得た。このものにつ
いて、真皮コラーゲン線維束再構築作用をイン・ビトロ
で調べた。即ち、3回/週の最小紅斑量の紫外線照射を
5週連続して行ったヘアレスマウス(Hr−/Kud,
雌)の背部皮膚より、小片を切り出し、トリプシン処理
をして皮膚由来の真皮線維芽細胞を採取し、5代継代し
て用いた。培養条件は5×104(5×10の4乗)個
/mlの細胞濃度で、1.0mg/mlの酸可溶性コラ
ーゲンを加え、10%FBS加イーグルの最少培地で1
0-4(10の−4乗)%の真皮コラーゲン線維束再構築
剤1を添加して7日間培養した。図1に0%添加(非添
加)の写真(図面代用写真)を図2に10-4(10の−
4乗)%添加の写真を示す。図1ではコラーゲン線維が
無秩序に分布しているのに対して、図2ではコラーゲン
線維が2、3本ずつまとまり、構造を作り始めているこ
とがわかる。これにより、本発明の真皮コラーゲン線維
束再構築剤1が、真皮に於いて真皮コラーゲンの再構築
を促していることがわかる。<Example 1> Chestnut (Sy
zygium aromaticum L. MERR. Et PERRY.) 500 g of dried flower buds, 5 l of methanol was added thereto, immersed at room temperature for 1 week, filtered, concentrated under reduced pressure, and the dermis collagen fiber bundle reconstituting agent of the present invention. 1 was obtained in an amount of 35 g. This was examined in vitro for its dermal collagen fiber bundle remodeling action. That is, a hairless mouse (Hr- / Kud,
A small piece was cut out from the back skin of the female) and trypsinized to collect dermal fibroblasts derived from the skin and used for 5 passages. Culture conditions were 5 × 10 4 (5 × 10 4) cells / ml, 1.0 mg / ml of acid-soluble collagen was added, and 1% in Eagle's minimal medium supplemented with 10% FBS.
0-4 (10 to the -4 power)% of dermis collagen fiber bundle remodeling agent 1 was added and cultured for 7 days. FIG. 1 shows a photograph of 0% addition (non-addition) (substitute drawing), and FIG.
The photograph of (4th power)% addition is shown. 1 shows that collagen fibers are randomly distributed, while FIG. 2 shows that a few collagen fibers are gathered together and a structure is being formed. This shows that the dermis collagen fiber bundle remodeling agent 1 of the present invention promotes the remodeling of dermal collagen in the dermis.
【0010】<実施例2>下記に示す処方に従って、本
発明の真皮コラーゲン線維束の崩壊又は構造の乱れに起
因する、しわの予防又は改善用の化粧料(化粧水)を作
成した。即ち、処方成分を70℃で加熱、攪拌、可溶化
し、攪拌冷却して化粧水を得た。 真皮コラーゲン線維束再構築剤1 0.1重量部 グリセリン 5 重量部 1,2−ペンタンジオール 4 重量部 ポリホスファチジルオキシエチルメタクリレート 0.1重量部 フェノキシエタノール 0.1重量部 エタノール 5 重量部 POE(60)硬化ひまし油 0.1重量部 水 85.6重量部Example 2 According to the following formulation, a cosmetic (lotion) for preventing or improving wrinkles due to the collapse of the dermal collagen fiber bundle or the disorder of the structure of the present invention was prepared. That is, the prescription component was heated, stirred, solubilized at 70 ° C., and stirred and cooled to obtain a lotion. Dermal collagen fiber bundle reconstituting agent 1 0.1 part by weight Glycerin 5 parts by weight 1,2-pentanediol 4 parts by weight Polyphosphatidyloxyethyl methacrylate 0.1 part by weight Phenoxyethanol 0.1 part by weight Ethanol 5 parts by weight POE (60) Hardened castor oil 0.1 parts by weight Water 85.6 parts by weight
【0011】<実施例3>上記実施例2の化粧水と、実
施例2の化粧水の真皮コラーゲン線維束再構築剤1を水
に置換した比較例1の化粧水に関して、1群5名のしわ
に悩むパネラーを用いて、長期連用試験(3ヶ月)を行
い、しわの改善を著効、効果あり、効果なしの3段階で
評価したところ、実施例2の使用テスト群では、4名に
著効、1名に効果ありが認められたが、比較例1は2名
が効果ありのみであった。これより、本発明の皮膚外用
剤である化粧水が、しわの改善に有効であると判断され
た。<Example 3> The lotion of Example 2 and the lotion of Comparative Example 1 in which the dermis collagen fiber bundle reconstituting agent 1 of Example 2 was replaced with water were used. A long-term continuous test (3 months) was conducted using panelists suffering from wrinkles, and the improvement of wrinkles was evaluated in three stages of significant, effective, and no effects. A remarkable effect was observed in one person, and an effect was observed in one person. However, in Comparative Example 1, only two persons were effective. From this, it was determined that the skin lotion, which is an external preparation for skin of the present invention, is effective in improving wrinkles.
【0012】<実施例4>以下に示す処方に従って、本
発明の乳液を作成した。即ち、イ、ロ及びハの成分をそ
れぞれ70℃に加熱し、イにロを加え中和し、これにハ
を徐々に加え乳化した。これを攪拌冷却し、本発明の皮
膚外用剤である乳液を作成した。このものを10名のパ
ネラーを対象に4週間の実使用テストを行ったところ、
5名に肌理の著効改善が観察され、3名に明かなハリの
向上が認められた。又、この様な効果を全く乃至は殆ど
認められないパネラーも2名存在し、これらのパネラー
の肌理のあれやハリの低下のメカニズムが真皮コラーゲ
ン線維束構造の崩壊や構造の乱れに起因しないことが推
測された。 イ 1,2−ペンタンジオール 5 重量部 イソプレングリコール 4 重量部 アクリル酸・メタクリル酸アルキルポリマー 0.6重量部 フェノキシエタノール 0.1重量部 水 30 重量部 ロ 10%水酸化カリウム水溶液 3 重量部 水 41.3重量部 ハ スクワラン 5 重量部 ホホバ油 5 重量部 オリーブ油 5 重量部 真皮コラーゲン線維束再構築剤1 1 重量部Example 4 An emulsion according to the present invention was prepared according to the following formulation. That is, the components (a), (b) and (c) were each heated to 70 ° C., (b) was neutralized by adding (b) to the mixture, and (c) was gradually added thereto to emulsify. This was stirred and cooled to prepare an emulsion as the external preparation for skin of the present invention. A four-week actual use test was conducted on this panel for 10 panelists.
In 5 persons, a marked improvement in the texture was observed, and in 3 persons, a clear improvement in firmness was recognized. There are also two panelists who do not or hardly recognize such an effect, and the mechanism of roughening and reduction of firmness of these panelers is not caused by collapse of the dermal collagen fiber bundle structure or disorder of the structure. Was speculated. A. 1,2-pentanediol 5 parts by weight isoprene glycol 4 parts by weight acrylic acid / alkyl methacrylate polymer 0.6 parts by weight phenoxyethanol 0.1 parts by weight water 30 parts by weight b 10% aqueous solution of potassium hydroxide 3 parts by weight water 41. 3 parts by weight Hassqualane 5 parts by weight Jojoba oil 5 parts by weight Olive oil 5 parts by weight Dermal collagen fiber bundle restructuring agent 1 1 part by weight
【0013】<実施例5>下記に示す処方に従って、パ
ック化粧料を作成した。即ち、処方成分を攪拌、均一化
しパック化粧料とした。このものは肌理、ハリの改善及
びしわ改善に有効であった。 酢酸ビニルエマルジョン 40 重量部 1,3−ブタンジオール 5 重量部 グリセリン 5 重量部 1,2−ペンタンジオール 5 重量部 真皮コラーゲン線維束再構築剤1 5 重量部 フェノキシエタノール 0.2重量部 エチルパラベン 0.1重量部 水 39.7重量部Example 5 A pack cosmetic was prepared according to the following formulation. That is, the prescription components were stirred and homogenized to obtain a pack cosmetic. This was effective for improving texture, firmness and wrinkles. Vinyl acetate emulsion 40 parts by weight 1,3-butanediol 5 parts by weight Glycerin 5 parts by weight 1,2-pentanediol 5 parts by weight Dermal collagen fiber bundle remodeling agent 1 5 parts by weight Phenoxyethanol 0.2 parts by weight Ethylparaben 0.1 Parts by weight water 39.7 parts by weight
【0014】[0014]
【発明の効果】本発明によれば、真皮コラーゲン線維束
構造を再構築する、新たな真皮コラーゲン線維束再構築
剤を提供することができる。According to the present invention, it is possible to provide a new dermis collagen fiber bundle remodeling agent for reconstructing a dermal collagen fiber bundle structure.
【図1】 実施例1のイン・ビトロ試験の真皮コラーゲ
ン線維束再構築剤無添加の試験結果を示す図である。
(図面代用写真)FIG. 1 is a view showing test results of an in vitro test of Example 1 without the addition of a dermis collagen fiber bundle remodeling agent.
(Drawing substitute photo)
【図2】 実施例1のイン・ビトロ試験の真皮コラーゲ
ン線維束再構築剤10-4%添加の試験結果を示す図であ
る。(図面代用写真)FIG. 2 is a view showing a test result of an in vitro test of Example 1 in which 10-4% of a dermis collagen fiber bundle remodeling agent was added. (Drawing substitute photo)
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61P 17/16 A61P 17/16 Fターム(参考) 4C083 AA111 AA112 AA122 AB032 AC022 AC102 AC112 AC122 AC172 AC432 AC482 AD092 AD112 CC02 CC04 CC05 CC07 EE12 EE13 4C088 AB57 AC01 AC03 AC04 AC05 AC11 BA10 CA06 MA63 ZA89──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) A61P 17/16 A61P 17/16 F-term (Reference) 4C083 AA111 AA112 AA122 AB032 AC022 AC102 AC112 AC122 AC172 AC432 AC482 AD092 AD112 CC02 CC04 CC05 CC07 EE12 EE13 4C088 AB57 AC01 AC03 AC04 AC05 AC11 BA10 CA06 MA63 ZA89
Claims (8)
センスからなる真皮コラーゲン線維束再構築剤。1. An agent for reconstructing dermal collagen fiber bundles comprising the essence of a plant belonging to the family Myrtaceae.
トモモ科チョウジノキ(Syzygium aromaticum L. MERR.
Et PERRY)であることを特徴とする、請求項1に記載
の真皮コラーゲン線維束再構築剤。2. A plant belonging to the family Myrtaceae, wherein the plant of the family Myrtaceae is Syzygium aromaticum L. MERR.
The dermal collagen fiber bundle reconstruction agent according to claim 1, wherein the agent is Et PERRY).
部、茎部、根部、果実、種子、花蕾から選ばれる1種乃
至は2種以上からなる極性溶媒抽出物乃至はその溶媒除
去物であることを特徴とする、請求項1又は2に記載の
真皮コラーゲン線維束再構築剤。3. A polar solvent extract or a solvent-removed product thereof, wherein the essence of the plant body is one or two or more selected from whole plants or leaves, stems, roots, fruits, seeds, and flower buds. The dermis collagen fiber bundle remodeling agent according to claim 1 or 2, characterized in that:
ラーゲン線維束再構築剤を含有する、しわの改善或いは
予防用の皮膚外用剤。4. A skin external preparation for improving or preventing wrinkles, comprising the dermis collagen fiber bundle remodeling agent according to any one of claims 1 to 3.
は構造の乱れに起因するものであることを特徴とする、
請求項4に記載の植物体のエッセンス。5. The method according to claim 1, wherein the wrinkles are caused by collapse of dermal collagen fiber bundles or structural disorder.
An essence of the plant according to claim 4.
センスを含有することを特徴とする、真皮コラーゲン線
維束の崩壊或いは構造の乱れに起因するしわの処置用の
皮膚外用剤。6. An external skin preparation for treating wrinkles caused by disruption of dermal collagen fiber bundles or structural disorder, comprising an essence of a plant of the family Myrtaceae.
トモモ科チョウジノキ(Syzygium aromaticum L. MERR.
Et PERRY)であるであることを特徴とする、請求項6
に記載の皮膚外用剤。7. The plant of the family Myrtaceae, wherein the plant of the family Myrtaceae is Syzygium aromaticum L. MERR.
Et PERRY).
2. The external preparation for skin according to item 1.
部、根部、全草から選ばれる1種乃至は2種以上からな
る極性溶媒の抽出物乃至はその溶媒除去物であることを
特徴とする、請求項6又は7に記載の皮膚外用剤。8. The essence of the plant is an extract of a polar solvent comprising one or more selected from flower buds, leaves, stems, roots, and whole plants, or a solvent-removed product thereof. 8. The external preparation for skin according to claim 6, wherein the external preparation is characterized in that:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000218808A JP2002029988A (en) | 2000-07-19 | 2000-07-19 | Corium collagen fiber bundle-restructuring agent and composition containing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000218808A JP2002029988A (en) | 2000-07-19 | 2000-07-19 | Corium collagen fiber bundle-restructuring agent and composition containing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002029988A true JP2002029988A (en) | 2002-01-29 |
JP2002029988A5 JP2002029988A5 (en) | 2007-06-21 |
Family
ID=18713706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000218808A Pending JP2002029988A (en) | 2000-07-19 | 2000-07-19 | Corium collagen fiber bundle-restructuring agent and composition containing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2002029988A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002104921A (en) * | 2000-09-29 | 2002-04-10 | Pola Chem Ind Inc | Corium collagen fiber bundle-reconstituting agent and composition containing the same agent |
JP2003183122A (en) * | 2001-12-21 | 2003-07-03 | Ichimaru Pharcos Co Ltd | Agent for inhibiting activity of collagenase |
EP1454620A3 (en) * | 2003-03-06 | 2005-04-13 | Kao Corporation | Skin aging-preventing or improving agent |
KR101354552B1 (en) | 2010-12-07 | 2014-01-23 | 한국생명공학연구원 | Composition for antiaging comprising the extract of Decaspermum fruticosum as an active ingredient |
US8865208B2 (en) | 2007-05-29 | 2014-10-21 | Pola Chemical Industries Inc. | Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH069371A (en) * | 1992-06-23 | 1994-01-18 | Mikimoto Pharmaceut Co Ltd | Hyaluronidase inhibitor |
JPH0624937A (en) * | 1992-06-29 | 1994-02-01 | Narisu Keshohin:Kk | Mucopolysaccharide fragmentation-inhibiting agent, active oxygen-scavenging agent, antioxidative agent and cosmetic |
JPH0717847A (en) * | 1993-06-30 | 1995-01-20 | Sansho Seiyaku Co Ltd | Skin external preparation |
JPH10130162A (en) * | 1996-10-31 | 1998-05-19 | Kanebo Ltd | Hyaluronic acid decomposition inhibitor, agent for treatment of hyaluronic acid abnormal decomposition disease and cosmetic |
JPH115727A (en) * | 1997-06-17 | 1999-01-12 | Pola Chem Ind Inc | Skin cosmetic |
JPH1112122A (en) * | 1997-06-20 | 1999-01-19 | Pola Chem Ind Inc | Skin-improving cosmetic |
JPH11246385A (en) * | 1998-03-03 | 1999-09-14 | Shiseido Co Ltd | Antiaging agent |
JPH11263720A (en) * | 1998-03-13 | 1999-09-28 | Shiseido Co Ltd | Antiaging agent |
JPH11318387A (en) * | 1989-10-31 | 1999-11-24 | Kanebo Ltd | Food product for anti-inflammation |
JP2000119125A (en) * | 1998-10-06 | 2000-04-25 | Kao Corp | Skin aging-preventing/improving agent |
JP2000119189A (en) * | 1998-10-06 | 2000-04-25 | Kao Corp | Elastase inhibitor |
JP2000247897A (en) * | 1999-02-26 | 2000-09-12 | Ichimaru Pharcos Co Ltd | Cosmetic composition |
JP2001058920A (en) * | 1999-08-20 | 2001-03-06 | Kao Corp | Cosmetic |
JP2001220312A (en) * | 2000-02-09 | 2001-08-14 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing steam distillate of plant |
JP2002003358A (en) * | 2000-06-23 | 2002-01-09 | Shiseido Co Ltd | Skin care preparation |
-
2000
- 2000-07-19 JP JP2000218808A patent/JP2002029988A/en active Pending
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11318387A (en) * | 1989-10-31 | 1999-11-24 | Kanebo Ltd | Food product for anti-inflammation |
JPH069371A (en) * | 1992-06-23 | 1994-01-18 | Mikimoto Pharmaceut Co Ltd | Hyaluronidase inhibitor |
JPH0624937A (en) * | 1992-06-29 | 1994-02-01 | Narisu Keshohin:Kk | Mucopolysaccharide fragmentation-inhibiting agent, active oxygen-scavenging agent, antioxidative agent and cosmetic |
JPH0717847A (en) * | 1993-06-30 | 1995-01-20 | Sansho Seiyaku Co Ltd | Skin external preparation |
JPH10130162A (en) * | 1996-10-31 | 1998-05-19 | Kanebo Ltd | Hyaluronic acid decomposition inhibitor, agent for treatment of hyaluronic acid abnormal decomposition disease and cosmetic |
JPH115727A (en) * | 1997-06-17 | 1999-01-12 | Pola Chem Ind Inc | Skin cosmetic |
JPH1112122A (en) * | 1997-06-20 | 1999-01-19 | Pola Chem Ind Inc | Skin-improving cosmetic |
JPH11246385A (en) * | 1998-03-03 | 1999-09-14 | Shiseido Co Ltd | Antiaging agent |
JPH11263720A (en) * | 1998-03-13 | 1999-09-28 | Shiseido Co Ltd | Antiaging agent |
JP2000119125A (en) * | 1998-10-06 | 2000-04-25 | Kao Corp | Skin aging-preventing/improving agent |
JP2000119189A (en) * | 1998-10-06 | 2000-04-25 | Kao Corp | Elastase inhibitor |
JP2000247897A (en) * | 1999-02-26 | 2000-09-12 | Ichimaru Pharcos Co Ltd | Cosmetic composition |
JP2001058920A (en) * | 1999-08-20 | 2001-03-06 | Kao Corp | Cosmetic |
JP2001220312A (en) * | 2000-02-09 | 2001-08-14 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing steam distillate of plant |
JP2002003358A (en) * | 2000-06-23 | 2002-01-09 | Shiseido Co Ltd | Skin care preparation |
Non-Patent Citations (2)
Title |
---|
伊藤 三明 MITSUAKI ITO: "特集/最近の香粧品における新原料・新技術", FRAGRANCE JOURNAL VOL.22, NO.2, vol. 第22巻, JPN6010046606, ISSN: 0001704330 * |
田中浩 他: "活性酸素の培養ヒト皮膚線維芽細胞におけるコラーゲン代謝に及ぼす影響", 日本化粧品技術者会誌, vol. 28, no. 2, JPN6010046605, 1994, pages 172 - 177, ISSN: 0001704329 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002104921A (en) * | 2000-09-29 | 2002-04-10 | Pola Chem Ind Inc | Corium collagen fiber bundle-reconstituting agent and composition containing the same agent |
JP2003183122A (en) * | 2001-12-21 | 2003-07-03 | Ichimaru Pharcos Co Ltd | Agent for inhibiting activity of collagenase |
EP1454620A3 (en) * | 2003-03-06 | 2005-04-13 | Kao Corporation | Skin aging-preventing or improving agent |
US8865208B2 (en) | 2007-05-29 | 2014-10-21 | Pola Chemical Industries Inc. | Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle |
KR101354552B1 (en) | 2010-12-07 | 2014-01-23 | 한국생명공학연구원 | Composition for antiaging comprising the extract of Decaspermum fruticosum as an active ingredient |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3053368B2 (en) | Cosmetic and method for producing the same | |
KR101516536B1 (en) | Composition for Preventing Hair Loss and Promoting Hair Growth and A method for manufacturing thereof | |
JP5889018B2 (en) | Scalp hair cosmetics | |
JPH10330222A (en) | Enderonic collagen fasciculus remedial agent | |
JP4789334B2 (en) | Skin preparation for wrinkle improvement and prevention | |
JP2008260721A (en) | External preparation for skin | |
JPH1129460A (en) | Cosmetic for sensitive skin | |
CA2461462A1 (en) | Cosmetic composition for human skin and hair care | |
JP6622015B2 (en) | External preparation for skin or cosmetics | |
JPH10330221A (en) | Enderonic collagen fasciculus remedial agent | |
JP3791775B2 (en) | Topical skin preparation | |
CN114681378A (en) | Blackhead-derived cosmetic composition and preparation method thereof | |
JP2002029988A (en) | Corium collagen fiber bundle-restructuring agent and composition containing the same | |
JP3742767B2 (en) | Hair conditioner consisting of extracts of Asagaokakaraksa and other herbal extracts | |
JP2002029986A (en) | Corium collagen fiber bundle-restructuring agent and composition containing the same | |
JP4392114B2 (en) | Dermal collagen fiber bundle reconstituting agent and composition containing the same | |
JP2002154919A (en) | Elongation inhibitor of dendrite of melanocyte and cosmetic comprising the same | |
JP2000109417A (en) | Cosmetic for improving somber color | |
JP2001181174A (en) | Cosmetic composition | |
JP4355091B2 (en) | Dermal collagen fiber bundle reconstituting agent and composition containing the same | |
JP2002020261A (en) | Agent for restructuring corium collagen fiber bundle and composition containing the same | |
JP3447667B2 (en) | External preparation for skin | |
JP2002154920A (en) | Elongation inhibitor of dendrite of melanocyte and cosmetic comprising the same | |
JP2002029987A (en) | Corium collagen fiber bundle-restructuring agent and composition containing the same | |
KR20210123547A (en) | A lightweight freeze-dried cosmetics) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070507 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070507 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20070507 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100824 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20101221 |